Alignment Healthcare, Inc. is a healthcare company founded in 2013 that provides Medicare Advantage plans for seniors in the United States. The company operates as a care management business, offering HMO and PPO contracts that cover hospital and physician care, prescription drugs, and supplemental benefits such as dental, vision, and non-emergency transportation. Alignment serves members in California, North Carolina, Nevada, Arizona, and Texas, utilizing a hybrid care model that combines virtual services with in-home clinical teams. The company utilizes its proprietary AVA (Alignment Virtual Application) platform, an artificial intelligence-based tool for predicting care needs, and offers 24/7 concierge member services. Alignment contracts directly with the Centers for Medicare & Medicaid Services under a capitated payment model, focusing on proactive chronic care management and cost reduction through integrated clinical and technology solutions.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Healthcare Plans Homepage alignmenthealth.com
Sector Healthcare IR page ir.alignmenthealth.com
Tags
medicare advantage, senior healthcare, care management, chronic disease management, virtual care, in-home services, concierge services, health insurance, hmo, ppo, AVA, Alignment Virtual Application, Care Anywhere, Alignment Health Plan
Press page —

Metrics

Valuation  
Market cap $ 1.506B
Market cap (USD) $ 1.506B
P/E 51.43
PEG —
P/BV 5.43
P/S 0.30
P/OCF 13.94
P/FCF 19.55
Dividend yield —
Turnover / mcap —
Returns  
ROE -0.52%
ROI -0.14%
ROIC 2.2%
Profit margin -0.02%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 117.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 25
Quality score 5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 3.949B 2.704B 1.801B 1.432B 1.167B 955.393M
Net profit -724K -128.035M -148.017M -149.547M -195.286M -22.926M
Free cash flow 113.146M -6.648M -95.182M -69.201M -97.136M —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 19.75 11.25 8.61 11.76 14.06 —
Price performance 12m 0.76 0.31 -0.27 -0.16 — —

Filed figures

Figure Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 40.1M 58.5M 92.9M 120M 154M 253M
↳ YoY growth +45.8% +58.8% +28.9% +28.5% +64.5%
↳ 5y CAGR +44.5%
Borrowings, current (USD) — — 0.00 0.00 0.00 0.00 0.00 0.00
Borrowings, non-current (USD) — — 144M 151M 161M 162M 321M 323M
Lease liabilities (USD) — — 10.3M 11M 8.02M 10.7M 9.05M 8.43M
Cash and deposits (USD) 34.9M 86.5M 208M 467M 410M 203M 433M 576M
Intangible assets (USD) — — 34.6M 35.1M 40.3M 5.25M 4.55M 4.55M
Right-of-use assets (USD) — 11.1M 9.89M 7.85M 5.83M 9.96M 7.82M 6.75M
Net debt (borrowings + leases - cash) (USD) — — -53.4M -305M -241M -30.4M -102M -244M
Cash flow detail
Operating cash flow (USD) — 9.21M 7.56M -78.8M -45.4M -59.2M 34.8M 140M
Purchases of property, plant and equipment (USD) — — — — -23.8M -36M -41.4M -26.8M
Change in receivables (cash effect) (USD) — -5.78M -4.63M -17.6M -34.4M -27M -34.3M -100M
Interest paid (cash effect) (USD) — -9.53M -10.7M -11M -22.4M -19.2M -22.2M -13.8M
Income taxes paid (cash effect) (USD) — — — — — -205,000 -20,000 -25,000
Share-based compensation (USD) — 0.00 446,000 621,000 0.00 0.00 71.1M 62.1M
Operating cash flow before change in receivables (USD) — 15M 12.2M -61.2M -11.1M -32.2M 69M 240M
Free cash flow (OCF - PPE - intangibles) (USD) — — — — -69.2M -95.2M -6.65M 113M
Income detail
Provision for credit losses (USD) — 1.42M 118,000 111,000 150,000 91,000 123,000 833,000
Credit cost ratio (credit losses / average receivables) (%) — — — 0.2% 0.2% 0.1% 0.1% 0.4%
Reported Mar 3, 2022 Mar 3, 2022 Mar 3, 2022 Mar 3, 2022 Feb 27, 2025 Feb 27, 2026 Feb 27, 2026 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Oct 29, 2026

PDF Version

  • Reports third-quarter revenue of $1.36 billion, representing 36.7% year-over-year growth

  • Grows health plan membership 31.2% year-over-year to 301,200 members

  • Issues fourth-quarter guidance and lowers full-year 2026 adjusted gross profit and adjusted EBITDA guidance

ORANGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its third quarter ended Sept. 30, 2026.

“Our third-quarter membership and revenue growth demonstrate continued demand for Alignment’s products and services, while medical trends ran higher than expected,” said John Kao, chairman and CEO. “We are taking a prudent approach to the fourth quarter and lowering our outlook based on current headwinds. Our revised guidance does not assume any benefit from the actions underway. We are confident we can deliver against these expectations. Our focus now is on execution and taking the steps necessary to drive more consistent performance as we scale and deliver profitable growth over the long term.”

Third Quarter 2026 Financial Highlights All comparisons, unless otherwise noted, are to the three months ended September 30, 2025.

  • Health plan membership at the end of the quarter was approximately 301,200, up 31.2% year-over-year

  • Total revenue was $1,358.3 million, up 36.7% year-over-year

  • Adjusted gross profit* was $142.2 million, up 11.6% year-over-year, and loss from operations was $3.8 million

    • Adjusted gross profit excludes depreciation and amortization of $8.1 million and selling, general, and administrative expenses of $136.4 million (which includes $16.0 million of equity-based compensation). Adjusted gross profit also excludes $1.5 million of equity-based compensation recorded within medical expenses
    • Medical benefits ratio based on adjusted gross profit was 89.5%, an increase of approximately 240 basis points year-over-year. The medical benefits ratio result reflects previously expected changes in Part D seasonality and timing of clinical investments, along with higher costs from elevated appeals and disputes and increased costs within catastrophic cases and skilled nursing categories
  • Adjusted EBITDA* of $21.8 million represented an adjusted EBITDA margin of 1.6% and declined 32.8% year-over-year, while net loss was $8.1 million, compared to net income of $3.7 million the year prior

  • Please see “Third Quarter 2026 Non-GAAP Reconciliation Tables” below for more information on the non-GAAP financial measures reported here as supplemental information.

Outlook for Fourth Quarter and Fiscal Year 2026 Full-year health plan membership and revenue guidance was raised to reflect continued sales momentum, while adjusted gross profit and adjusted EBITDA guidance was lowered to reflect higher medical costs experienced during the third quarter.

| | | Three Months Ending December 31, 2026 | | Twelve Months Ending December 31, 2026 | |

| $ Millions | No Less Than | | No Less Than | |

| Health Plan Membership | 305,000 | | 305,000 | |

| Revenue | $1,316 | | $5,245 | |

| Adjusted Gross Profit(1) | $104 | | $575 | |

| Adjusted EBITDA(1) | $(28) | | $100 | |

| | | | | | |

| | | | | | |

| | | | | | |

| (1) | Adjusted gross profit and adjusted EBITDA are non-GAAP financial measures presented as supplemental disclosure. We cannot provide estimated ranges for the most directly comparable GAAP measures without unreasonable efforts because of the uncertainty around certain items that may impact such GAAP measures, including equity-based compensation expense and depreciation and amortization, that are not within our control or cannot be reasonably predicted. See “Third Quarter 2026 Non-GAAP Reconciliation Tables” for additional information. |

| | |

Third Quarter 2026 Non-GAAP Reconciliation Tables

Adjusted Gross Profit(1) is reconciled as follows:

| | | Three Months Ended September 30, | | Nine Months Ended September 30, | |

| | | 2026 | | 2025 | | 2026 | | 2025 | |

| (dollars in thousands) | | | | | | | | | | | | | |

| Income (loss) from operations | $ | (3,794 | ) | | $ | 7,681 | | $ | 53,809 | | $ | 25,036 | |

| Add back: | | | | | | | | | | | | | |

| | Equity-based compensation (medical expenses) | | 1,511 | | | | 1,775 | | | 4,815 | | | 4,521 | |

| | Depreciation (medical expenses) | | 7 | | | | 8 | | | 33 | | | 74 | |

| | Depreciation and amortization(2) | | 8,108 | | | | 7,977 | | | 23,801 | | | 22,574 | |

| | Selling, general, and administrative expenses | | 136,373 | | | | 110,015 | | | 388,514 | | | 317,643 | |

| | Total add back | | 145,999 | | | | 119,775 | | | 417,163 | | | 344,812 | |

| Adjusted gross profit | $ | 142,205 | | | $ | 127,456 | | $ | 470,972 | | $ | 369,848 | |

| | | | | | | | | | | | | | | |

| (1) | Adjusted gross profit is a non-GAAP financial measure that is presented as supplemental disclosure, that we define as income (loss) from operations before depreciation and amortization, medical equity-based compensation expense, and selling, general, and administrative expenses. |

| | | | | | | | | | | | | | | |

| (2) | Amortization expense for the nine months ended September 30, 2025, includes $0.6 million in impairment expense related to the remeasurement of goodwill associated with one of our subsidiaries. There was no impairment expense for the three months ended September 30, 2025. |

| | | | | | | | | | | | | | | |

Adjusted EBITDA(1) is reconciled as follows:

| | | Three Months Ended September 30, | | Nine Months Ended September 30, | |

| | | 2026 | | 2025 | | 2026 | | 2025 | |

| (dollars in thousands) | | | | | | | | | | | | | | | |

| Net income (loss) | $ | (8,052 | ) | | $ | 3,729 | | $ | 39,924 | | | $ | 10,028 | | |

| Less: Net loss attributable to noncontrolling interest | | — | | | | — | | | — | | | | (254 | ) | |

| Adjustments: | | | | | | | | | | | | | | | |

| | Interest expense | | 4,280 | | | | 3,950 | | | 12,617 | | | | 11,850 | | |

| | Depreciation and amortization(2) | | 8,115 | | | | 7,985 | | | 23,834 | | | | 22,648 | | |

| | Income tax expense | | (22 | ) | | | 2 | | | 1,269 | | | | 3,247 | | |

| | Equity-based compensation(3) | | 17,487 | | | | 16,227 | | | 49,680 | | | | 48,967 | | |

| | Litigation costs(4) | | — | | | | 546 | | | 481 | | | | 1,608 | | |

| | Gain on sale of property and equipment | | — | | | | — | | | (1 | ) | | | (72 | ) | |

| Adjusted EBITDA | $ | 21,808 | | | $ | 32,439 | | $ | 127,804 | | | $ | 98,530 | | |

| | | | | | | | | | | | | | | | | |

| (1) | Adjusted EBITDA is a non-GAAP financial measure that is presented as supplemental disclosure, that we define as net income (loss) before interest expense, income taxes, depreciation and amortization expense, certain litigation costs, gains or losses on sale of property and equipment, and equity-based compensation expense. |

| | | | | | | | | | | | | | | | | |

| (2) | Amortization expense for the nine months ended September 30, 2025 includes $0.6 million in impairment expense related to the remeasurement of goodwill associated with one of our subsidiaries. There was no impairment expense for the three months ended September 30, 2025. |

| | | | | | | | | | | | | | | | | |

| (3) | Represents equity-based compensation related to grants made in the applicable year. |

| | | | | | | | | | | | | | | | | |

| (4) | Represents litigation costs considered outside of the ordinary course of business based on the following considerations which we assess regularly: (i) the frequency of similar cases that have been brought to date, or are expected to be brought within two years, (ii) complexity of the case, (iii) nature of the remedies sought, (iv) litigation posture of the Company, (v) counterparty involved, and (vi) the Company's overall litigation strategy. |

| | |

Conference Call Details The company will host a conference call at 5 p.m. EDT today to discuss these results and management’s outlook for future financial and operational performance. A live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/o7dsxqqm. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web links, and will remain available for approximately 12 months.

About Alignment Health Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.

Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and our financial outlook for the quarter and year ending Dec. 31, 2026. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully execute our business plan and achieve anticipated operational improvements and financial results; our ability to manage changes in medical costs and healthcare utilization, and our ability to accurately estimate, price for and manage such costs and utilization; our ability to attract new members and enter new markets, including the need for certain governmental approvals; our ability to achieve and maintain a high rating for our plans on the Five Star Quality Rating System; our ability to develop and maintain satisfactory relationships with care providers that service our members; risks associated with being a government contractor, including potential federal reductions in MA funding; changes in laws and regulations applicable to our business model; risks related to our indebtedness; changes in market or industry conditions and receptivity to our technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in our labor costs. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our Annual Report on Form 10-K for the year ended Dec. 31, 2025, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 and the other periodic reports we file with the SEC. All information provided in this release and in the attachments is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.

| Condensed Consolidated Balance Sheets(in thousands, except par value and share amounts) (Unaudited) |

| |

| | September 30, 2026 | | December 31, 2025 | |

| Assets | | | | | | | | |

| Current Assets: | | | | | | | | |

| Cash and cash equivalents | $ | 727,694 | | | $ | 575,817 | | |

| Accounts receivable (less allowance for credit losses of $699 at September 30, 2026 and $833 at December 31, 2025) | | 242,545 | | | | 253,207 | | |

| Investments - current | | 15,260 | | | | 28,413 | | |

| Prepaid expenses and other current assets | | 192,808 | | | | 94,140 | | |

| Total current assets | | 1,178,307 | | | | 951,577 | | |

| Property and equipment, net | | 66,439 | | | | 64,251 | | |

| Right of use asset, net | | 7,206 | | | | 7,019 | | |

| Goodwill | | 32,060 | | | | 32,060 | | |

| Intangible assets, net | | 4,550 | | | | 4,550 | | |

| Other assets | | 8,301 | | | | 6,329 | | |

| Total assets | $ | 1,296,863 | | | $ | 1,065,786 | | |

| Liabilities and Stockholders' Equity | | | | | | | | |

| Current Liabilities: | | | | | | | | |

| Medical expenses payable | $ | 621,746 | | | $ | 474,569 | | |

| Accounts payable and accrued expenses | | 34,562 | | | | 33,284 | | |

| Accrued compensation | | 32,744 | | | | 49,013 | | |

| Total current liabilities | | 689,052 | | | | 556,866 | | |

| Long-term debt, net of debt issuance costs | | 324,497 | | | | 323,176 | | |

| Long-term portion of lease liabilities | | 6,202 | | | | 6,467 | | |

| Total liabilities | | 1,019,751 | | | | 886,509 | | |

| Stockholders' Equity: | | | | | | | | |

| Preferred stock, $0.001 par value; 100,000,000 shares authorized as of September 30, 2026 and December 31, 2025, respectively; no shares issued and outstanding as of September 30, 2026 and December 31, 2025 | | — | | | | — | | |

| Common stock, $0.001 par value; 1,000,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 209,152,387 and 204,153,619 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | | 209 | | | | 205 | | |

| Additional paid-in capital | | 1,245,996 | | | | 1,188,089 | | |

| Accumulated deficit | | (969,093 | ) | | | (1,009,017 | ) | |

| Total stockholders' equity | | 277,112 | | | | 179,277 | | |

| Total liabilities and stockholders' equity | $ | 1,296,863 | | | $ | 1,065,786 | | |

| |

| Condensed Consolidated Statements of Operations(in thousands, except per share amounts) (Unaudited) |

| |

| | Three Months Ended September 30, | | Nine Months Ended September 30, | |

| | 2026 | | 2025 | | 2026 | | 2025 | |

| Revenues: | | | | | | | | | | | | | | | |

| Earned premiums | $ | 1,348,256 | | | $ | 983,681 | | $ | 3,901,447 | | | $ | 2,907,927 | | |

| Other | | 10,034 | | | | 10,014 | | | 27,673 | | | | 27,988 | | |

| Total revenues | | 1,358,290 | | | | 993,695 | | | 3,929,120 | | | | 2,935,915 | | |

| Expenses: | | | | | | | | | | | | | | | |

| Medical expenses | | 1,217,603 | | | | 868,022 | | | 3,462,996 | | | | 2,570,662 | | |

| Selling, general, and administrative expenses | | 136,373 | | | | 110,015 | | | 388,514 | | | | 317,643 | | |

| Depreciation and amortization | | 8,108 | | | | 7,977 | | | 23,801 | | | | 22,574 | | |

| Total expenses | | 1,362,084 | | | | 986,014 | | | 3,875,311 | | | | 2,910,879 | | |

| Income (loss) from operations | | (3,794 | ) | | | 7,681 | | | 53,809 | | | | 25,036 | | |

| Other expenses: | | | | | | | | | | | | | | | |

| Interest expense | | 4,280 | | | | 3,950 | | | 12,617 | | | | 11,850 | | |

| Other income, net | | — | | | | — | | | (1 | ) | | | (89 | ) | |

| Total other expense | | 4,280 | | | | 3,950 | | | 12,616 | | | | 11,761 | | |

| Income (loss) before income taxes | | (8,074 | ) | | | 3,731 | | | 41,193 | | | | 13,275 | | |

| Provision (benefit) for income taxes | | (22 | ) | | | 2 | | | 1,269 | | | | 3,247 | | |

| Net income (loss) | $ | (8,052 | ) | | $ | 3,729 | | $ | 39,924 | | | $ | 10,028 | | |

| Less: Net loss attributable to noncontrolling interest | | — | | | | — | | | — | | | | (254 | ) | |

| Net income (loss) attributable to Alignment Healthcare, Inc. | $ | (8,052 | ) | | $ | 3,729 | | $ | 39,924 | | | $ | 10,282 | | |

| | | | | | | | | | | | | | | | |

| Net income (loss) per share attributable to Alignment Healthcare, Inc.: | | | | | | | | | | | | | | | |

| Basic | | (0.04 | ) | | | 0.02 | | | 0.19 | | | | 0.05 | | |

| Diluted | | (0.04 | ) | | | 0.02 | | | 0.19 | | | | 0.05 | | |

| Weighted-average common shares outstanding: | | | | | | | | | | | | | | | |

| Basic | | 208,556,942 | | | | 199,026,808 | | | 207,132,468 | | | | 197,007,141 | | |

| Diluted | | 208,556,942 | | | | 208,927,980 | | | 214,815,296 | | | | 208,439,200 | | |

| |

| Condensed Consolidated Statements of Cash Flows(in thousands) (Unaudited) |

| |

| | Nine Months Ended September 30, | |

| | 2026 | | 2025 | |

| Operating Activities: | | | | | | | | |

| Net income | $ | 39,924 | | | $ | 10,028 | | |

| Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | |

| Provision for credit loss | | 699 | | | | 548 | | |

| Gain on sale of property and equipment | | (1 | ) | | | (72 | ) | |

| Depreciation and amortization | | 23,834 | | | | 22,648 | | |

| Amortization-investment discount | | (478 | ) | | | (1,041 | ) | |

| Amortization-debt issuance costs | | 1,790 | | | | 1,321 | | |

| Equity-based compensation | | 49,680 | | | | 48,967 | | |

| Non-cash lease expense | | 1,439 | | | | 1,178 | | |

| Changes in operating assets and liabilities: | | | | | | | | |

| Accounts receivable | | 9,963 | | | | (66,451 | ) | |

| Prepaid expenses and other current assets | | (98,668 | ) | | | (84,326 | ) | |

| Other assets | | (9 | ) | | | (47 | ) | |

| Medical expenses payable | | 147,177 | | | | 239,008 | | |

| Accounts payable and accrued expenses | | 1,004 | | | | 11,185 | | |

| Accrued compensation | | (16,269 | ) | | | 8,349 | | |

| Lease liabilities | | (1,690 | ) | | | (993 | ) | |

| Net cash provided by operating activities | | 158,395 | | | | 190,302 | | |

| Investing Activities: | | | | | | | | |

| Purchase of investments | | (32,510 | ) | | | (45,194 | ) | |

| Sale of property and equipment | | — | | | | 75 | | |

| Maturities of investments | | 46,135 | | | | 57,995 | | |

| Sale of business | | — | | | | 1,065 | | |

| Acquisition of property and equipment | | (25,952 | ) | | | (21,752 | ) | |

| Net cash used in investing activities | | (12,327 | ) | | | (7,811 | ) | |

| Financing Activities: | | | | | | | | |

| Debt issuance costs | | (2,397 | ) | | | (26 | ) | |

| Proceeds from stock option exercises | | 8,231 | | | | 2,771 | | |

| Net cash provided by financing activities | | 5,834 | | | | 2,745 | | |

| Net increase in cash | | 151,902 | | | | 185,236 | | |

| Cash, cash equivalents and restricted cash at beginning of period | | 577,937 | | | | 434,942 | | |

| Cash, cash equivalents and restricted cash at end of period | $ | 729,839 | | | $ | 620,178 | | |

| Supplemental disclosure of cash flow information: | | | | | | | | |

| Cash paid for interest | $ | 7,013 | | | $ | 6,740 | | |

| Supplemental non-cash investing and financing activities: | | | | | | | | |

| Acquisition of property in accounts payable | $ | 9 | | | $ | 79 | | |

| |

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the total above:

| | September 30, 2026 | | September 30, 2025 | |

| Cash and cash equivalents | $ | 727,694 | | $ | 618,067 | |

| Restricted cash in other assets | | 2,145 | | | 2,111 | |

| Total | $ | 729,839 | | $ | 620,178 | |

| |

Non-GAAP Financial Measures

Certain of these financial measures are considered “non-GAAP” financial measures within the meaning of Item 10 of Regulation S-K promulgated by the SEC. We believe that non-GAAP financial measures provide an additional way of viewing aspects of our operations that, when viewed with the GAAP results, provide a more complete understanding of our results of operations and the factors and trends affecting our business. These non-GAAP financial measures are also used by our management to evaluate financial results and to plan and forecast future periods. However, non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Non-GAAP financial measures used by us may differ from the non-GAAP measures used by other companies, including our competitors. To supplement our consolidated financial statements presented on a GAAP basis, we disclose the following non-GAAP measures: Medical Benefits Ratio, Adjusted EBITDA and Adjusted Gross Profit as these are performance measures that our management uses to assess our operating performance. Because these measures facilitate internal comparisons of our historical operating performance on a more consistent basis, we use these measures for business planning purposes and in evaluating acquisition opportunities.

Adjusted EBITDA

Adjusted EBITDA is a non-GAAP financial measure that we define as net income (loss) before interest expense, income taxes, depreciation and amortization expense, certain litigation costs, gains or losses on sale of property and equipment, and equity-based compensation expense.

Adjusted EBITDA should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are a number of limitations related to the use of Adjusted EBITDA in lieu of net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP.

Our use of the term Adjusted EBITDA may vary from the use of similar terms by other companies in our industry and accordingly may not be comparable to similarly titled measures used by other companies.

Medical Benefits Ratio (MBR)

We calculate our MBR by dividing total medical expenses, excluding depreciation, and medical equity-based compensation, by total revenues in a given period.

Adjusted Gross Profit

Adjusted gross profit is a non-GAAP financial measure that we define as income (loss) from operations before depreciation and amortization, medical equity-based compensation expense, and selling, general, and administrative expenses.

Adjusted gross profit should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are a number of limitations related to the use of adjusted gross profit in lieu of income (loss) from operations, which is the most directly comparable financial measure calculated in accordance with GAAP.

Our use of the term adjusted gross profit may vary from the use of similar terms by other companies in our industry and accordingly may not be comparable to similarly titled measures used by other companies.

Investor Contact Harrison Zhuo [email protected]

Media Contact Jerry Slowey [email protected]

STAY INFORMED

Oct 22, 2026

PDF Version

New plan strengthens Alignment’s Arizona portfolio available to nearly 1.1 million Medicare beneficiaries across Maricopa, Pima and Santa Cruz counties

PHOENIX, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage plan from Alignment Health, today announced a new Medicare Advantage plan for Pima County beginning Jan. 1, 2027, offering Pima County seniors access to low-cost coverage, local providers, bilingual support and coordinated care designed to help them stay healthy and independent. With the addition of Alignment Health ONE (HMO), Alignment Health Plan will now offer seven Medicare Advantage plans across Maricopa, Pima and Santa Cruz counties, which are home to nearly 1.1 million Medicare beneficiaries, according to data from the Centers for Medicare & Medicaid Services1.

Alignment Health ONE (HMO) is also available as Alignment Health UNICO, a community-focused plan for Hispanic seniors that offers bilingual services, a low maximum out-of-pocket limit, a $2,500 dental allowance and a monthly allowance for groceries and other health-related needs.

With seven Medicare Advantage plans and a network of more than 15,000 primary care physicians and specialists, Alignment continues to expand its presence across Arizona while giving seniors more options to choose coverage that fits their health and financial needs. Plans include a variety of options designed to meet the diverse needs of Medicare beneficiaries, with offerings that emphasize affordability, personalized care and support for chronic health conditions.

“Every senior deserves the peace of mind that comes from knowing they have access to quality care, trusted local providers and support when they need it most,” said Dawn Maroney, president of Alignment Health and CEO of Alignment Health Plan. “That’s what we strive to deliver at Alignment: coordinated, personalized care that helps seniors feel supported and confident throughout their health journey.”

Access to Trusted Care Close to Home

Members have access to a broad network of primary care physicians, specialists, hospitals and community-based providers across Arizona, helping ensure care is available when and where it is needed.

  • Suvida Healthcare in Maricopa and Pima counties. Members enrolled in designated plans can access Suvida Healthcare’s primary care providers and neighborhood centers in Phoenix and Tucson. Bilingual care teams include physicians, nurses, physical and mental health therapists, clinical pharmacists, dietitians and Suvida “Guías” (Spanish for “guides”).

  • CareMore Health in Maricopa County. With expanded access in mind, Alignment is extending its CareMore Health relationship to give members more primary care choices and coordinated support for chronic conditions and specialty care.

Proven Quality and Member Experience

For 2027, Alignment’s Arizona HMO contract is rated 4 stars, reflecting Alignment’s consistent ability to deliver high-quality service and responsive care across communities in the state. Every year, Medicare evaluates plans based on a 5-star rating system.

Plans and Support Built Around Members

Alignment’s 2027 Arizona portfolio offers plan choices designed around members’ health and financial needs. Alignment Health ONE + Walgreens (HMO) plans continue across Maricopa, Pima and Santa Cruz counties, offering exclusive over-the-counter access through Walgreens, while Alignment Health Smart (HMO) offers members a monthly rebate toward their Medicare Part B premium. Qualifying members living with diabetes or certain heart conditions can also choose specialized plans with Essentials allowances for groceries and everyday health-related expenses2.

Every Alignment member has access to a 24/7 concierge team that helps coordinate care, navigate benefits and connect members to the support they need. Depending on the plan, members may also enjoy benefits such as $0 copays on more than 10,000 prescribed medications, over-the-counter and grocery2 allowances, fitness programs and in-home support.

At a time when many Arizona seniors are reevaluating their Medicare coverage options, Alignment continues to expand access to affordable plans, coordinated care and trusted provider relationships across the state.

Medicare’s Annual Enrollment Period runs Oct. 15 through Dec. 7, 2026, with coverage taking effect Jan. 1, 2027. To learn more about Alignment Health’s 2027 Medicare Advantage plans in Arizona, visit alignmenthealthplan.com or call 1-888-979-2247.3

About Alignment Health

Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.

Media Contact: Jerry Slowey [email protected]

Y0141_27449EN_M


1 Centers for Medicare & Medicaid Services Medicare Advantage/Part D Contract and Enrollment Data, September 2026 MA State/County Penetration 2 Special supplemental benefits for the chronically ill (SSBCI)-qualifying chronic conditions include congestive heart failure (CHF), dementia, diabetes, and stroke. Other chronic conditions may apply. Medical records will be used to establish the member qualification. The benefits mentioned are a part of a special supplemental program for the chronically ill. Not all members qualify because other eligibility and coverage criteria also apply. 3 Alignment Health Plan is an HMO, HMO POS, HMO C-SNP, HMO D-SNP and PPO plan with a Medicare contract and a contract with the California, Nevada, North Carolina and Texas Medicaid programs. Enrollment in Alignment Health Plan depends on contract renewal. The benefit information provided is a summary, not a complete description of benefits. For more information, contact the plan. Call 1-888-979-2247 (TTY: 711), 8 a.m. to 8 p.m. Monday through Friday, for more information. Other providers are available in our network.

STAY INFORMED

Oct 21, 2026

PDF Version

Expansion extends Alignment’s Nevada presence to three counties, home to more than 554,000 Medicare beneficiaries

LAS VEGAS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage plan from Alignment Health, today announced it will expand into Nye County beginning Jan. 1, 2027, offering new Medicare Advantage plan options to local seniors. With the expansion, Alignment Health Plan will serve Clark, Nye and Washoe counties, which are home to more than 554,000 Medicare beneficiaries, according to the Centers for Medicare & Medicaid Services (CMS) data1.

With the addition of Nye County, Alignment Health’s 2027 Nevada portfolio features six Medicare Advantage plans across three counties supported by more than 6,500 physicians and access to premier provider partners. People with Medicare living in the service area can choose from a co-branded plan with Intermountain Health, plans with Instacart, a plan that helps reduce their Medicare Part B premium and specialized plans for people living with diabetes or heart conditions.

“Choosing the right Medicare coverage and getting the care you need shouldn’t be a challenge,” said Dawn Maroney, president of Alignment Health and CEO of Alignment Health Plan. “We’re excited to expand into Nye County and serve more Nevada seniors with the kind of care and support that treats them as people, not policies. By connecting members to trusted local providers and personalized guidance, we can help them spend less time navigating the health care system and more time focusing on what matters most: staying healthy, independent and engaged in their communities.”

Building on Trusted Nevada Provider Relationships

Members have access to nearby primary care providers, specialists and hospitals through health systems and medical groups in Clark, Nye and Washoe counties.

  • Intermountain Health in Clark and Nye counties. Through Alignment's relationship with Intermountain Health, members in Clark and Nye counties have access to coordinated care delivered through one of the region's leading healthcare systems, including senior-focused primary care, specialty care, urgent care and telehealth services.

  • Trusted local providers. Clark County members can also see providers from The Valley Health System, University Medical Center, Dignity Health and UNLV Health, and Washoe County members have access to providers from Prime Healthcare and Pinnacle Medical Group, among others.

Proven Quality and Member Experience

For 2027, Alignment’s Nevada HMO contract is rated 4 out of 5 stars, and its HMO contract that includes the Clark County Platinum + Instacart and Smart plans is rated 4.5 out of 5 stars. Medicare evaluates plans annually using a 5-star rating system to help consumers compare quality and performance, with higher ratings reflecting strong performance across measures such as member experience, customer service and care coordination.

More Choice and Support for Nevada Seniors

Alignment Health's 2027 Medicare Advantage plans are designed to help Nevada seniors find coverage that fits their health needs, budget and lifestyle. Alignment Health + Intermountain Health (HMO), available in Clark and Nye counties, lowers its out-of-pocket maximum for 2027. In Clark County, Alignment Health Platinum + Instacart (HMO) includes a quarterly grocery allowance on Instacart for qualifying members, and Alignment Health Smart (HMO) helps reduce members’ Medicare Part B premium.

Members living with diabetes or heart conditions can choose Heart & Diabetes (HMO C-SNP) in Clark and Washoe counties, with up to $204 monthly Essentials allowance for eligible groceries and everyday health-related expenses2.

All members have access to Alignment’s 24/7 concierge team for personalized support, including help understanding their benefits, finding the right doctor, coordinating care and receiving answers when they need them. Depending on the plan, members may also enjoy benefits such as $0 copays on more than 10,000 prescribed medications, over-the-counter and grocery2 allowances, fitness programs and in-home support.

Medicare’s Annual Enrollment Period runs Oct. 15 through Dec. 7, 2026, with coverage taking effect Jan. 1, 2027. To learn more about Alignment Health’s 2027 Medicare Advantage plans in Nevada, visit alignmenthealthplan.com or call 1-888-979-2247.3

About Alignment Health

Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.

Media Contact: Jerry Slowey [email protected]

Y0141_27444EN_M

1 Centers for Medicare & Medicaid Services Medicare Advantage/Part D Contract and Enrollment Data, September 2026 MA State/County Penetration 2 Special supplemental benefits for the chronically ill (SSBCI)-qualifying chronic conditions include congestive heart failure (CHF), dementia, diabetes, and stroke. Other chronic conditions may apply. Medical records will be used to establish the member qualification. The benefits mentioned are a part of a special supplemental program for the chronically ill. Not all members qualify because other eligibility and coverage criteria also apply. 3 Alignment Health Plan is an HMO, HMO POS, HMO C-SNP, HMO D-SNP and PPO plan with a Medicare contract and a contract with the California, Nevada, North Carolina and Texas Medicaid programs. Enrollment in Alignment Health Plan depends on contract renewal. The benefit information provided is a summary, not a complete description of benefits. For more information, contact the plan. Call 1-888-979-2247 (TTY: 711), 8 a.m. to 8 p.m. Monday through Friday, for more information. Other providers are available in our network.

STAY INFORMED

Prompts

Alignment Healthcare, Inc. (ticker ALHC), listed in United States.

ETFs Holding Alignment Healthcare, Inc.

ETF Weight in ETF Shares Market value As of
ASCE 2.15% 106,517 $ 2.536M Jun 30, 2026
CPAI 2.01% 310,833 $ 7.401M Jun 30, 2026
LGHT 1.88% 1,950 $ 46.43K Jun 30, 2026
FMED 0.58% 22,200 $ 297.48K Aug 31, 2026
SEIS 0.56% 136,495 $ 3.25M Jun 30, 2026
TMED 0.50% 4,840 $ 115.24K Jun 30, 2026
FSEG 0.35% 833 $ 19.834K Jun 30, 2026
SMIZ 0.34% 69,009 $ 924.721K Aug 31, 2026
PSC 0.27% 259,553 $ 6.18M Jun 30, 2026
RESM 0.22% 334 $ 7,952.54 Jun 30, 2026
OASC 0.17% 11,962 $ 160.291K Aug 31, 2026
JMEE 0.17% 648,816 $ 4.944M Nov 17, 2026
ESSC 0.16% 3,944 $ 58.568K Jul 31, 2026
FSML 0.13% 6,992 $ 166.48K Jun 30, 2026
FESM 0.11% 261,005 $ 6.215M Jun 30, 2026
AVSC 0.07% 310,384 $ 2.319M Nov 16, 2026
VFQY 0.06% 22,325 $ 299.155K Aug 31, 2026
IALT short -0.04% -372,396 $ -2.782M Nov 16, 2026
FTLS short -0.03% -111,851 $ 0.00 Nov 16, 2026
SMDX 0.03% 5,213 $ 38.941K Nov 17, 2026
DFAS 0.03% 1,299,461 $ 9.746M Nov 12, 2026
VFMO 0.03% 39,008 $ 522.707K Aug 31, 2026
AVIE 0.02% 471 $ 3,518.37 Nov 16, 2026
MSSM 0.02% 9,282 $ 124.379K Aug 31, 2026
AVUS 0.01% 146,206 $ 1.092M Nov 16, 2026
AVUQ 0.01% 6,865 $ 51.282K Nov 16, 2026
DXUV 0.01% 64,439 $ 483.293K Nov 12, 2026
DFSU 0.01% 20,484 $ 153.63K Nov 12, 2026
FHEQ 0.00% 1,527 $ 22.676K Jul 31, 2026
DFUS 0.00% 54,926 $ 411.945K Nov 12, 2026
DFAC 0.00% 169,555 $ 1.272M Nov 12, 2026
DCOR 0.00% 86,168 $ 646.26K Nov 12, 2026
DFAU 0.00% 8,896 $ 66.72K Nov 12, 2026
EBI 0.00% 15 $ 201.00 Aug 31, 2026
AVSU 0.00% 1,058 $ 7,903.26 Nov 16, 2026